
SATURN V CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IVVD | 7.74M | $19.11M |
![]() | XFOR | 5.80M | $23.20M |
![]() | AMLX | 4.50M | $54.32M |
![]() | IKT | 3.86M | $7.91M |
![]() | ALMS | 3.14M | $30.61M |
![]() | IMMX | 3.00M | $15.69M |
![]() | OVID | 2.50M | $4.08M |
![]() | DYN | 1.79M | $34.99M |
![]() | OCUL | 1.50M | $18.27M |
![]() | COGT | 1.22M | $43.23M |
![]() | PHVS | 1.14M | $31.64M |
![]() | PCVX | 799K | $36.86M |
![]() | ABVX | 649K | $87.55M |
![]() | MNPR | 326K | $21.27M |
![]() | CELC | 317K | $31.63M |
![]() | IRON | 298K | $23.70M |
![]() | IVA | 283K | $1.32M |
![]() | CNTA | 283K | $7.07M |
![]() | JAZZ | 248K | $42.17M |

Invivyd, Inc.
IVVD
Shares Held
7.74M
Value
$19.11M

X4 Pharmaceuticals, Inc.
XFOR
Shares Held
5.80M
Value
$23.20M

Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
4.50M
Value
$54.32M

Inhibikase Therapeutics, Inc.
IKT
Shares Held
3.86M
Value
$7.91M

Alumis Inc. Common Stock
ALMS
Shares Held
3.14M
Value
$30.61M

Immix Biopharma, Inc.
IMMX
Shares Held
3.00M
Value
$15.69M

Ovid Therapeutics Inc.
OVID
Shares Held
2.50M
Value
$4.08M

Dyne Therapeutics, Inc.
DYN
Shares Held
1.79M
Value
$34.99M

Ocular Therapeutix, Inc.
OCUL
Shares Held
1.50M
Value
$18.27M

Cogent Biosciences, Inc.
COGT
Shares Held
1.22M
Value
$43.23M

Pharvaris N.V.
PHVS
Shares Held
1.14M
Value
$31.64M

Vaxcyte, Inc.
PCVX
Shares Held
799K
Value
$36.86M

Abivax S.A.
ABVX
Shares Held
649K
Value
$87.55M

Monopar Therapeutics Inc.
MNPR
Shares Held
326K
Value
$21.27M

Celcuity Inc.
CELC
Shares Held
317K
Value
$31.63M

Disc Medicine, Inc.
IRON
Shares Held
298K
Value
$23.70M

Inventiva S.A.
IVA
Shares Held
283K
Value
$1.32M

Centessa Pharmaceuticals plc
CNTA
Shares Held
283K
Value
$7.07M

Jazz Pharmaceuticals plc
JAZZ
Shares Held
248K
Value
$42.17M
